← signals
2026-07-04·ASML·export restriction risk signal
lowdown

Multiple prediction market outcomes on Manifold Markets as of July 4, 2026, indicate elevated risk of future US export...

Multiple prediction market outcomes on Manifold Markets as of July 4, 2026, indicate elevated risk of future US export restrictions on ASML.

window 30devidence 11confidence score 91price ASML $1843.04

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate
priced-in check

ASML has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-07-017d n/a45d n/a90d +40%yahoo

signal brief

Multiple prediction market outcomes on Manifold Markets as of July 4, 2026, indicate elevated risk of future US export restrictions on ASML. Notably, the market assigns a 47.56% probability that the US will cut off ASML's access to Cymer (a key EUV light source supplier) before 2030 (source 1), and a 50% probability that the US will force ASML to halt exports to China before 2029 (source 8). These figures suggest significant geopolitical risk to ASML's supply chain and China revenue. On the bullish side, markets assign a 79.92% probability that ASML remains the sole EUV producer through end 2026 (source 3) and an 83.77% probability of annual revenue growth over five years (source 4). However, the relatively high probabilities for export restrictions outweigh the bullish sentiment, as any restriction would materially impact ASML's top line and technological edge.

What the sources said:

  • Source 1: "Will the US cut ASML off Cymer before 2030? YES=47.56%" indicates nearly even odds of a critical supply chain disruption.
  • Source 8: "Will the US force ASML to halt exports to China before 2029? YES=50.00%" shows a coin-flip probability of losing China market access.
  • Source 7: "Will China invent a domestic version of ASML’s EUV lithographic machine tool by January 1, 2030? YES=56.45%" suggests a rising chance of ASML losing its monopoly position.

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.